Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea
· Delayed Price · Currency is KRW 11,210
+70 (0.63%)
At close: Apr 17, 2025, 3:30 PM KST
Ildong Pharmaceutical Revenue
In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B KRW with 2.36% growth. Ildong Pharmaceutical had revenue of 155.74B in the quarter ending December 31, 2024, with 3.08% growth.
Revenue
614.94B
Revenue Growth
+2.36%
P/S Ratio
0.51
Revenue / Employee
595.30M
Employees
1,033
Market Cap
316.47B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |